Do screening blood tests always improve health outcomes?

What question did the researchers ask?

Researchers examined screening for 19 diseases using nine meta-analyses and 48 randomised trials, asking whether testing asymptomatic adults reduced disease-specific or all-cause mortality.

What did they actually find?

Clear reductions were uncommon: four disease-specific mortality estimates and no all-cause mortality meta-analysis excluded no effect. In individual trials, only a minority of estimates showed a mortality reduction.

What should you keep in mind?

This broad review does not mean clinically indicated tests lack value. It shows why a blood test should answer a defined question: low-risk screening can still produce false positives, incidental findings and unnecessary follow-up.

What does this mean for a Highfield consultation?

Testing is most useful when it answers a clinical question; broad screening can also create false positives and further investigation. We consider that finding alongside independent guidance, your medical history, examination and priorities. It can support a better-informed decision, but it cannot promise a personal result or decide whether treatment is suitable.